Chemoinformaics analysis of 6-Methylhept-5-en-2-ol
Molecular Weight | 128.215 | nRot | 3 |
Heavy Atom Molecular Weight | 112.087 | nRig | 1 |
Exact Molecular Weight | 128.12 | nRing | 0 |
Solubility: LogS | -1.244 | nHRing | 0 |
Solubility: LogP | 1.552 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 24.8307 |
nHD | 1 | BPOL | 16.0513 |
QED | 0.388 |
Synth | 2.053 |
Natural Product Likeliness | 1.829 |
NR-PPAR-gamma | 0.038 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.004 |
HIA | 0.004 |
CACO-2 | -4.346 |
MDCK | 0.0000255 |
BBB | 0.984 |
PPB | 0.311073 |
VDSS | 1.171 |
FU | 0.756102 |
CYP1A2-inh | 0.578 |
CYP1A2-sub | 0.802 |
CYP2c19-inh | 0.078 |
CYP2c19-sub | 0.632 |
CYP2c9-inh | 0.03 |
CYP2c9-sub | 0.708 |
CYP2d6-inh | 0.022 |
CYP2d6-sub | 0.373 |
CYP3a4-inh | 0.019 |
CYP3a4-sub | 0.147 |
CL | 7.511 |
T12 | 0.708 |
hERG | 0.11 |
Ames | 0.556 |
ROA | 0.132 |
SkinSen | 0.957 |
Carcinogencity | 0.185 |
EI | 0.991 |
Respiratory | 0.964 |
NR-Aromatase | 0.018 |
Antiviral | No |
Prediction | 0.955514 |